BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19701967)

  • 1. Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma.
    Ma XM; Yu H; Huai N
    World J Gastroenterol; 2009 Aug; 15(31):3874-83. PubMed ID: 19701967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells.
    Wang Y; Tan H; Xu D; Ma A; Zhang L; Sun J; Yang Z; Liu Y; Shi G
    Int J Mol Med; 2014 Jul; 34(1):262-8. PubMed ID: 24820432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
    Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.
    Fujita M; Tohji C; Honda Y; Yamamoto Y; Nakamura T; Yagami T; Yamamori M; Okamura N
    Int J Med Sci; 2012; 9(7):555-66. PubMed ID: 22991494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats.
    Takagi T; Naito Y; Ichikawa H; Tomatsuri N; Katada K; Isozaki Y; Kuroda M; Kokura S; Yoshida N; Yoshikawa T
    Redox Rep; 2004; 9(6):376-81. PubMed ID: 15720836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo.
    Wei Z; Jiang X; Liu F; Qiao H; Zhou B; Zhai B; Zhang L; Zhang X; Han L; Jiang H; Krissansen GW; Sun X
    Tumour Biol; 2013 Feb; 34(1):181-92. PubMed ID: 23229098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21.
    Shen ZN; Nishida K; Doi H; Oohashi T; Hirohata S; Ozaki T; Yoshida A; Ninomiya Y; Inoue H
    Biochem Biophys Res Commun; 2005 Mar; 328(2):375-82. PubMed ID: 15694358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression.
    Kamagata C; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2007 May; 102(3):263-73. PubMed ID: 17028981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
    Dong YW; Wang XP; Wu K
    World J Gastroenterol; 2009 Jan; 15(4):441-8. PubMed ID: 19152448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
    Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
    Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H
    Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
    Kondoh K; Tsuji N; Asanuma K; Kobayashi D; Watanabe N
    Exp Cell Res; 2007 Oct; 313(16):3486-96. PubMed ID: 17706193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.
    Subbarayan V; Sabichi AL; Kim J; Llansa N; Logothetis CJ; Lippman SM; Menter DG
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1710-6. PubMed ID: 15533897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
    Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
    Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of overexpression of S phase kinase-associated protein 2 with reduced expression of p27 and PTEN in human gastric carcinoma.
    Ma XM; Liu Y; Guo JW; Liu JH; Zuo LF
    World J Gastroenterol; 2005 Nov; 11(42):6716-21. PubMed ID: 16425372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro.
    Liu JJ; Huang RW; Lin DJ; Peng J; Wu XY; Lin Q; Pan XL; Song YQ; Zhang MH; Hou M; Chen F
    Ann Oncol; 2005 Mar; 16(3):455-9. PubMed ID: 15642706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.